About Step Pharma

Step Pharma is discovering and developing novel therapeutics that inhibit the enzyme CTP Synthase 1 (CTPS1).

Step Pharma was created on the basis of research on genetic immunodeficiencies led by Prof. Alain Fischer at the Imagine Institute (Paris, France) which established the essential role of CTPS1 in T- and B-cell proliferation.

Read more about us

Latest news

10 May 2022

Step Pharma Strengthens Clinical Development Team Ahead of First in Human Studies

Paris, France, 6 September 2019 – Step Pharma, a biotech company developing novel drugs for autoimmune diseases, today…

Read more

17 November 2021

Step Pharma Establishes Clinical Advisory Board

Read More

6 October 2021

Step Pharma Appoints Experienced Cancer Drug Developer Adrian Senderowicz to Board of Directors

Read More

Upcoming events

Step Pharma will be present at the following events

Nothing found.

Share this page

Step Pharma

Forum 2
218 avenue Marie Curie
74160 Archamps
France

Contact us for more information